MedPath

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Not Applicable
Completed
Conditions
Stroke
Interventions
Device: Sentinel® Cerebral Protection System
Registration Number
NCT04149535
Lead Sponsor
Boston Scientific Corporation
Brief Summary

To demonstrate that use of the Sentinel® Cerebral Protection System significantly reduces the risk of peri-procedural stroke (≤72 hours) after transcatheter aortic valve replacement (TAVR).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Subject has documented aortic valve stenosis and is treated with an approved TAVR device via transfemoral access
  • Subject has the recommended artery diameter at the site of filter placement per the Sentinel® Cerebral Protection System Instructions For Use: 9-15 mm for the brachiocephalic artery and 6.5-10 mm in the left common carotid artery.
  • Subject (or legal representative) provides written informed consent.
Exclusion Criteria
  • Subject has arterial stenosis >70% in either the left common carotid artery or the brachiocephalic artery.
  • Subject's brachiocephalic or left carotid artery reveals significant stenosis, ectasia, dissection, or aneurysm at the aortic ostium or within 3 cm of the aortic ostium.
  • Subject has compromised blood flow to the right upper extremity.
  • Subject has access vessels with excessive tortuosity.
  • Subject has uncorrected bleeding disorders.
  • Subject is contraindicated for anticoagulant and antiplatelet therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAVR with SentinelSentinel® Cerebral Protection SystemPatients assigned to this group will undergo TAVR with the Sentinel® Cerebral Protection System.
Primary Outcome Measures
NameTimeMethod
The Rate of Stroke Through 72 Hours Post TAVR Procedure or Discharge (Whichever Comes First)<=72 hours

All stroke (hemorrhagic, ischemic, or undetermined status; disabling or nondisabling) through 72 hours post TAVR procedure or discharge (whichever comes first), as adjudicated by an independent Clinical Events Committee (CEC) and using Neurologic Academic Research Consortium (NeuroARC) definitions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (56)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Lahey Clinic Hospital

🇺🇸

Burlington, Massachusetts, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Piedmont Hosptial

🇺🇸

Atlanta, Georgia, United States

Baylor Heart and Vascular

🇺🇸

Dallas, Texas, United States

The Methodist Hospital

🇺🇸

Houston, Texas, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Medstar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

University of Iowa Hospitals and Clinics

🇺🇸

Iowa City, Iowa, United States

CHU La Timone Hospital

🇫🇷

Marseille, France

Kaiser Foundation Hospital - San Francisco

🇺🇸

San Francisco, California, United States

Abbott Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

Centennial Medical Center

🇺🇸

Nashville, Tennessee, United States

Vanderbilt

🇺🇸

Nashville, Tennessee, United States

Methodist Healthcare System of San Antonio dba Methodist Hospital

🇺🇸

San Antonio, Texas, United States

University of California, Davis Medical Center

🇺🇸

Sacramento, California, United States

Wake Forest University School of Medicine

🇺🇸

Winston-Salem, North Carolina, United States

Aurora St. Luke's Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

Tucson Medical Center

🇺🇸

Tucson, Arizona, United States

Los Robles Regional Medical Center

🇺🇸

Thousand Oaks, California, United States

South Denver Cardiology Associates PC and Swedish medical center

🇺🇸

Littleton, Colorado, United States

Intercoastal Medical Group

🇺🇸

Sarasota, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

St. Johns Hospital

🇺🇸

Springfield, Illinois, United States

Wellstar

🇺🇸

Marietta, Georgia, United States

Community Munster

🇺🇸

Munster, Indiana, United States

Sparrow Hospital

🇺🇸

Lansing, Michigan, United States

Kaleida Health

🇺🇸

Buffalo, New York, United States

Jersey Shore University Medical Center

🇺🇸

Neptune, New Jersey, United States

Englewood Medical Center

🇺🇸

Englewood, New Jersey, United States

Creighton - Bergan Cardiology

🇺🇸

Omaha, Nebraska, United States

Oregon Health Sciences University

🇺🇸

Portland, Oregon, United States

NYU Winthrop

🇺🇸

Mineola, New York, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Baptist Memorial

🇺🇸

Memphis, Tennessee, United States

Lankenau

🇺🇸

Wynnewood, Pennsylvania, United States

The Heart Hospital Baylor Plano

🇺🇸

Plano, Texas, United States

Baylor Scott and White

🇺🇸

Round Rock, Texas, United States

Monash Medical Center

🇦🇺

Clayton, Victoria, Australia

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Universitaetsklinikum Ulm

🇩🇪

Ulm, Germany

Rigshospitalet

🇩🇰

København, Denmark

Clinique Pasteur

🇫🇷

Toulouse, France

The Prince Charles Hospital

🇦🇺

Chermside, Australia

Heart Center Leipzig

🇩🇪

Bad Segeberg, Germany

Herzzentrum Dresden GmbH

🇩🇪

Dresden, Germany

University Hospital Frankfurt

🇩🇪

Frankfurt, Germany

Policlinico San Donato

🇮🇹

San Donato, Milanese, Italy

Universitaetsklinikum Schleswig-Holstein

🇩🇪

Lübeck, Germany

LMU Klinikum der Universität München

🇩🇪

Münich, Germany

Fondazione Centro San Raffaele

🇮🇹

Milan, Italy

Maria Cecilia Hospital SPA

🇮🇹

Cotignola, Italy

Mercy Hospital Medical Center

🇺🇸

Des Moines, Iowa, United States

Research Medical Center

🇺🇸

Kansas City, Missouri, United States

Heart Hospital of Austin

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath